NCT00375609View on ClinicalTrials.gov

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

PHASE2CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

February 28, 2007

Conditions
Thromboembolism
Interventions
DRUG

Betrixaban

Capsule

DRUG

Enoxaparin

Administered subcutaneously

Trial Locations (1)

H3Y 3B8

Montreal General Hospital, Montreal

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY